A PHASE-II RANDOMIZED TRIAL OF 13-CIS RETINOIC ACID (CRA) AND INTERFERON ALFA-2A (IFN) IN THE TREATMENT OF PLEXIFORM NEUROFIBROMA (PN) IN PATIENTS WITH NEUROFIBROMATOSIS TYPE-1 (NF1)

Authors
NEEDLE MN MOLLOY PT PACKER R FRIEDMAN HS COHEN BH JAKACKI R KORF B VAUGHAN SN PHILLIPS PC
Citation
Mn. Needle et al., A PHASE-II RANDOMIZED TRIAL OF 13-CIS RETINOIC ACID (CRA) AND INTERFERON ALFA-2A (IFN) IN THE TREATMENT OF PLEXIFORM NEUROFIBROMA (PN) IN PATIENTS WITH NEUROFIBROMATOSIS TYPE-1 (NF1), Pediatric research, 37(4), 1995, pp. 151-151
Citations number
NO
Categorie Soggetti
Pediatrics
Journal title
Pediatric research → ACNP
ISSN journal
00313998
Volume
37
Issue
4
Year of publication
1995
Part
2
Pages
151 - 151
Database
ISI
SICI code
0031-3998(1995)37:4<151:APRTO1>2.0.ZU;2-O